Bayer Agrees to $7.25 Billion Roundup Settlement for Cancer Claims

Bayer Agrees to $7.25 Billion Roundup Settlement for Cancer Claims

Agrochemical and biotechnology major Bayer has reached a nationwide settlement that will see it pay billions of dollars to individuals who allege its Roundup herbicide caused cancer.

On Friday, a judge in Missouri granted final approval to the agreement, which may cost the company as much as $7.25 billion in the coming years. The funds are earmarked for thousands of plaintiffs who have received, or are expected to receive, diagnoses of non-Hodgkin lymphoma, a type of blood cancer that they link to glyphosate, the primary ingredient in Roundup.

According to the circuit court order, eligible claimants may receive compensation ranging from $10,000 to $165,000. The specific amounts are determined by variables such as the individual’s level of exposure to glyphosate through their occupation—particularly in agriculture—and the age at which they were diagnosed with the disease.

Bill Anderson, the Chief Executive Officer of Bayer, described the agreement as a decisive milestone that will mitigate legal risks associated with pending and future litigation. Presiding Judge Timothy Boyer noted that the deal is among the largest in the history of mass tort personal injury class action settlements.

Christopher Seeger, the attorney representing the plaintiffs, said that the final approval order ensures guaranteed compensation for victims who had been seeking justice for over a decade. The new settlement is supplemental to a previous agreement in which Bayer committed to paying between $10 billion and $11 billion to resolve more than 100,000 related Roundup claims.

The legal landscape shifted earlier this year when the U.S. Supreme Court ruled in favor of Bayer, the German company that currently owns Monsanto. The Court determined that the firm could be shielded from certain lawsuits filed in state courts regarding claims that it failed to warn consumers about the potential cancer-causing effects of glyphosate. Despite these rulings, Bayer has consistently denied that its products cause cancer, a position that contrasts with a conclusion from the World Health Organization’s cancer agency more than a decade ago that glyphosate is probably carcinogenic to humans.

3 responses to “Bayer Agrees to $7.25 Billion Roundup Settlement for Cancer Claims”

Leave a Reply

Your email address will not be published. Required fields are marked *